In February, the American Medical Association advised diabetes drugs like Januvia can double the risk of pancreatitis, a major risk factor for pancreatic cancer.
Los Angeles, CA (PRWEB) September 28, 2013
The diabetes drug safety center at DrugNews.net is advising patients taking the medications Januvia or Janumet of new information on the site. The latest court records show the number of lawsuits alleging the drugs caused cancer have risen*.
DrugNews provides those patients taking popular prescription drugs like Januvia with the latest warnings, recalls, studies and legal news in an effort to improve safety. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Januvia and Janumet are popular diabetes medications sold by Merck, prescribed to those with type-2 diabetes to lower blood sugar levels.
However, the resource center has added warnings from health experts that the drugs may be linked to cancer. In 2011, researchers from UCLA discovered subjects given Januvia had increased rates of pancreatic cancer and thyroid cancer**.
In February, the American Medical Association advised diabetes drugs like Januvia can double the risk of pancreatitis, a major risk factor for pancreatic cancer***. DrugNews also learned of a study by the Institute for Safe Medication Practices finding indications in FDA reports that patients taking drugs like Januvia have elevated risks of pancreatic cancer****.
Now, with a growing number of patients filing a Januvia lawsuit alleging cancer, federal cases have been consolidated to a special multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).
DrugNews has learned that the latest update from the Judicial Panel on Multidistrict Litigation shows 60 cases have now been filed since the creation of the MDL court alleging cancer from Januvia, Janumet, Byetta or Victoza*.
Anyone affected by cancer after taking Januvia or Janumet is encouraged to visit the DrugNews Center or speak with a lawyer about their legal options. However, due to the specialized nature of these cases, DrugNews only recommends lawyers who have already handled Januvia lawsuits.
For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*Judicial Panel on Multidistrict Litigation, 9/11/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-11-2013.pdf
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****ISMP QuarterWatch April, 2013; ismp.org/QuarterWatch/pdfs/2012Q3.pdf